Français
ItalianoBond AdvanzPharm 9.5% ( USC26215AB61 ) in USD
| Issuer | AdvanzPharm |
| Market price | 100 % ▲ |
| Country |  Canada
|
| ISIN code |
 USC26215AB61 ( in USD )
|
| Interest rate | 9.5% per year ( payment 2 times a year) |
| Maturity | 21/10/2022 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 790 000 000 USD |
| Cusip | C26215AB6 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Advanz Pharma is a pharmaceutical company focused on developing and commercializing branded and generic prescription drugs, primarily in the areas of gastroenterology, pain management, and central nervous system disorders. The Bond issued by AdvanzPharm ( Canada ) , in USD, with the ISIN code USC26215AB61, pays a coupon of 9.5% per year. The coupons are paid 2 times per year and the Bond maturity is 21/10/2022 |